Article
Small cell lung cancer: Novel treatments beyond immunotherapy
11 May 2022
Abstract excerpt
Small cell lung cancer (SCLC) arises in peribronchial locations and infiltrates the bronchial submucosa, including about 15% of lung cancer cases. Despite decades of research, the prognosis for SCLC patients remains poor because this tumor is characterized by an exceptionally high proliferative rate, strong tendency for early widespread metastasis and acquired chemoresistance. Omics profiling revealed that SCLC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
